Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk

Overview of attention for article published in Vascular Health and Risk Management, March 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 152 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 23 publications that cite this research output.

23

The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.

Epicardial left atrial appendage clipping versus direct oral anticoagulant to reduce stroke risk in non-paroxysmal atrial fibrillation (LAA-CLIP): rationale, design and study protocol for a multicentre randomised controlled trial

Article in BMJ Open (March 2024)

Chapter 5 Acquired disorders of hemostasis

Book chapter (January 2024)

Exploring safety and efficacy of rivaroxaban after living donor liver transplantation: a retrospective study

Article in Langenbeck's Archives of Surgery (August 2023)